Research Article

An In Silico Study of the Interactions of Alkaloids from Cryptolepis sanguinolenta with Plasmodium falciparum Dihydrofolate Reductase and Dihydroorotate Dehydrogenase

Table 6

Thermodynamics of binding of selected C. sanguinolenta alkaloids-PfDHFR complexes obtained from the entire duration (50 ns) of the molecular dynamics’ simulation

PL complexEnergies (kJmol−1)
ΔEvdWΔEelecΔGPBΔGSASAΔGbind

wt-PfDHFR
Biscryptolepine−149.12−33.47113.92−17.1185.79
Cryptomisrine−217.59−51.47162.26−24.02130.82
Cryptospirolepine−153.72−20.9877.03−17.44115.11
Cryptolepine−112.22180.06132.17−11.63188.37
Cryptoheptine−109.87−11.2560.45−13.3173.98
Cryptolepinone−85.58−8.4551.56−9.9252.39
Hydroxycryptolepine−125.91188.66114.33−13.21163.87

dm-PfDHFR
Biscryptolepine−210.73−30.67160.10−23.29104.60
Cryptomisrine−130.48−354.0860.40−17.86442.02
Cryptospirolepine−2.982−0.74525.01−0.34820.93
Cryptolepine−112.37238.48116.31−11.61230.81
Cryptoheptine−92.41−12.3453.25−11.4062.91
Cryptolepinone−114.78−29.2897.26−12.7959.59
Hydroxycryptolepine−115.36363.41173.56−13.12408.49

qm-PfDHFR
Biscryptolepine−192.16−24.38135.55−21.75102.74
Cryptomisrine−122.00−381.58122.59−16.60397.59
Cryptospirolepine−156.17−17.5879.98−18.71−112.48
Cryptolepicarboline−183.48242.51108.59−20.00147.63
Cryptoheptine−105.59−25.3189.18−13.1854.89
Cryptolepinone−79.92−10.0951.25−9.6048.37
Neocryptolepine−121.10264.6574.05−13.75203.84
Hydroxycryptolepine−132.41247.4381.40−14.58181.84

PL, protein-ligand.